Current and Emerging Medications: Name Type Status Tirzepatide Dual GLP-1 / GIP Agonist FDA Approved CagriSema Dual GLP-1 / Amylin AgonistIn Phase 3 Trials Retatrutide Triple GIP / GLP-1 / GlucagonIn Phase 3 Trials These multi-pathway drugs aim to improve results but may also come with more side effects
For instance, hydroxycobalamin is stored in the body longer than cyanocobalamin, reducing the need for frequent injections
For WorldatWork Members Total Rewards Inventory of Programs & Practices, research 5 Health Benefits Trends Come into Focus for 2024, Workspan Magazine article Navigating Employees Serious Medical Needs, on-demand webinar Total Rewards Inventory Checklist, tool For Everyone Employer Healthcare Costs Projected to Hit 10-Year High in 2025, Workspan Daily article Employers Look to Balance Rising Health Costs, Benefit Upgrades in 2025, Workspan Daily article As Health Costs Spike, Total Rewards and CFO Collaboration Is Crucial, Workspan Daily article Employers Grapple with the Rising Costs and Popularity of Specialty Weight-Loss Drugs, Workspan Daily article With the glucagon-like peptide-1 (or GLP-1) class of drugs now approved by the U.S
Starting with achievable, structured goals, such as regular walking combined with resistance training (like weight lifting) a few times per week, is a practical approach